My ePortfolio Register   
 

Abstract | Full HTML Article | PDF ecancer 10 691 / https://doi.org/10.3332/ecancer.2016.691

Conference Report

Cancer Immunotherapy: from the lab to clinical applications. Potential impact on cancer centres’ organisation

This report covers the Immunotherapy sessions of the 2016 Organisation of European Cancer Institutes (OECI) Oncology Days meeting, which was held on 15th–17th June 2016 in Brussels, Belgium. Immunotherapy is a potential cancer treatment that uses an individual’s immune system to fight the tumour. In recent years significant advances have been made in this field in the treatment of several advanced cancers. Cancer immunotherapies include monoclonal antibodies that are designed to attack a very specific part of the cancer cell and immune checkpoint inhibitors which are molecules that stimulate or block the inhibition of the immune system. Other cancer immunotherapies include vaccines and T cell infusions. This report will summarise some of the research that is going on in this field and will give us an update on where we are at present.

Keywords: Immunotherapy, monoclonal antibodies, cancer vaccines

Loading Article Metrics ... Please wait

Related articles

Research: Nursing intervention in women who developed lymphedema after undergoing a modified radical mastectomy: a pre-experimental study

Abstract | Full Article | PDF | Spanish Published: 19 Apr 2018 / https://doi.org/10.3332/ecancer.2018.827

Research: Evidence on the cost of breast cancer drugs is required for rational decision making

Abstract | Full Article | PDF Published: 16 Apr 2018 / https://doi.org/10.3332/ecancer.2018.825

Review: Adipose tissue stem cells in regenerative medicine

Abstract | Full Article | PDF | Spanish Published: 28 Mar 2018 / https://doi.org/10.3332/ecancer.2018.822

Research: Obesity and outcome of post-menopausal women receiving adjuvant letrozole for breast cancer

Abstract | Full Article | PDF Published: 26 Mar 2018 / https://doi.org/10.3332/ecancer.2018.821

Conference Report: Highlights from the 10th Breast, Gynaecological and Immunotherapy International Cancer Conference (BGICC), 18–19 January 2018, Cairo, Egypt

Abstract | Full Article | PDF Published: 22 Mar 2018 / https://doi.org/10.3332/ecancer.2018.820



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence